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Abstract  
Microvascular dysfunctions due to altered interactions between endothelial cells (ECs) and pericytes are 
key-events in the pathogenesis of diabetic retinopathy. Extracellular vesicles (EVs) derived from 
mesenchymal stem cells cultured in diabetic-like conditions enter pericytes, cause their detachment and 
migration, and stimulate angiogenesis. We recently showed that EVs from diabetic patients with 
retinopathy have different miRNA profiling patterns from healthy controls, and determine features of 
retinopathy in in vitro models of retinal microvasculature. In particular, a role for intra-vesicle miR-150-5p, 
miR-21-3p and miR-30b-5p was hypothesized. In this work, we further characterized EVs from subjects with 
diabetic retinopathy and investigated miR-150-5p, miR-21-3p and miR-30b-5p functions inside 
microvascular cells. Human retinal pericytes and ECs were transfected with mimics or inhibitors, as 
appropriate, of miR-21-3p, miR-30b-5p and miR-150-5p, to evaluate their ability in promoting cell migration 
and tube formation. mRNA and protein profiling of EVs extracted from diabetic subjects with (DR group) or 
without retinopathy (noDR group), and healthy controls (CTR group) were also performed. Modulation of 
miR-150-5p, miR-21-3p and miR-30b-5p inside microvascular cells confirmed their involvement in abnormal 
angiogenesis. mRNA analysis revealed differing expression of 7 genes involved in angiogenesis, while 
subsequent protein analysis confirmed increased expression of HIF-1α in DR group. Since all these 
molecules are involved in the hypoxia-induced retinal damage characteristic of the disease, our data 
reinforce the hypothesis of a potential use of miR-150-5p, miR-21-3p and miR-30b-5p extracted from 
circulating EVs as prognostic biomarkers for diabetic retinopathy. 
 
Keywords: diabetic retinopathy; extracellular vesicles; angiogenesis; hypoxia; miR-150-5p; miR-21-3p; miR-30b-5p; 
HIF-1α 
Abbreviations: Ang1, angiopoietin-1; Ago2, argonaute 2; ApoA1, apolipoprotein A1; CCL11, eotaxin; CTR, group of 
healthy controls; DR, group of diabetic patients with retinopathy; EC, endothelial cell; ECM, extracellular matrix; ENG, 
endoglin; EV, extracellular vesicles; GM130, Golgin subfamily A member 2; HMEC, human microvascular endothelial 
cells; HRP, human retinal pericytes; HIF-1α, hypoxia-inducible factor 1 α; miRNA, miR, microRNA; MISEV, Minimal 
information for studies of extracellular vesicles; MSC, mesenchymal stem cells; noDR, group of diabetic patients 
without retinopathy; NRP1, neuropilin-1; TIE1, tyrosine kinase with Ig and EGF (epidermal growth factor) homology 
domains (angiopoietin receptor); TIMP1, tissue inhibitor of metalloproteinases; TSG101, Tumor Susceptibility Gene 
101;VEGF, vascular endothelial growth factor; VEGFR1/2, vascular endothelial growth factor receptor 1/2 
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1. Introduction 
Microvascular dysfunction due to altered interactions between endothelial cells (ECs) and pericytes are 
early events in the pathogenesis of diabetic retinopathy, eventually leading to abnormal angiogenesis. 
Extracellular vesicles (EVs) are small membrane particles, containing microRNAs (miRNAs), mRNAs, proteins 
and lipids, and carrying information from cell to cell (Camussi et al., 2010). They are released into the blood 
flow by several cell types, especially in stress conditions, including diabetes (Müller, 2012). Increased EV 
concentrations in the plasma of diabetic patients have been reported (Feng et al., 2009; Müller, 2012; 
Mazzeo et al., 2018). EVs could play a role in vascular complications, such as diabetic retinopathy, since 
they can influence vascular permeability and angiogenesis (Müller, 2012). Therefore, they could be 
investigated as potential biomarkers of the disease. 
MiRNAs are small non-coding nucleotide sequences, which exercise a negative regulatory effect on their 
target mRNAs (Fabbri et al., 2008). They can be shuttled by EVs from cell to cell (Valadi et al., 2007) and are 
often related to a pathological state. In fact, they are currently under investigation as biomarkers of chronic 
diseases, such as diabetes (Guay and Regazzi, 2013; Snowhite et al., 2017), and diabetic retinopathy 
(Mastropasqua et al., 2014). 
We demonstrated that EVs derived from mesenchymal stem cells cultured in diabetic-like conditions enter 
the pericytes, cause their detachment and migration, and stimulate angiogenesis (Beltramo et al, 2014; 
Mazzeo et al., 2015). We have also shown that circulating EVs from diabetic patients with retinopathy have 
different miRNA profiling patterns from those of both diabetic subjects without complications and healthy 
controls. In particular, EVs derived from patients with diabetic retinopathy are able to determine 
pathological changes in microvascular cells compatible with those characteristics of the disease. We 
hypothesized that intra-vesicle miR-150-5p, miR-21-3p and miR-30b-5p could be novel potential biomarkers 
for the onset and progression of diabetic retinopathy (Mazzeo et al., 2018).  
In this work, we aimed at further characterizing EVs extracted by diabetic subjects with or without 
retinopathy and healthy controls, by addressing their mRNA and protein content. In addition, we 
investigated the functions and mechanisms of miR-150-5p, miR-21-3p and miR-30b-5p inside microvascular 
cells, by selectively inhibiting or mimicking their action to better evaluate their role in vessel homeostasis.  
 
2. Materials and methods 
2.1 Subjects 
Three age- and gender-matched groups were examined: 7 type 1 subjects (DR group) with proliferative 
diabetic retinopathy, but no other complications of diabetes, systemic or autoimmune diseases; 7 diabetic 
subjects without retinopathy (noDR group) and 7 healthy controls (CTR group). The subject characteristics 
are described in Mazzeo et al. (2018). Informed consent was obtained from all participants, and ethical 
clearance for involvement of human subjects in research was obtained from the Comitato Etico 
Interaziendale A.O.U. Città della Salute e della Scienza di Torino - A.O. Ordine Mauriziano - A.S.L. TO1. 
Overnight fasting venous blood samples were collected in tubes containing EDTA for plasma separation.  
2.2 Cell cultures 
A stabilized human retinal pericyte line (HRPs) is currently available in our laboratory (Berrone et al., 2009), 
while human microvascular ECs (HMECs) were purchased from Lonza (Basel, Switzerland). HRPs were 
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cultured in DMEM + 10% FCS, while HMECs in EBM-2 growth medium (Lonza). When used in the 
experiments, both HRPs and HMECs were maintained in DMEM + 10% FCS. Reagents for cell cultures were 
purchased from Sigma-Aldrich (St Louis, MO, USA). 
2.3 EV separation and characterization 
EVs were separated from plasma samples by two-step centrifugation: at 3000 g for 30 min to remove 
debris, apoptotic bodies and platelets, and at 100,000 g (average g at the middle of the tube, speed 40164 
rpm, K-factor 125) for 3 hrs at 4°C of the cell-free supernatants (ultracentrifuge Optima L-100K, equipped 
with rotor 90 Ti, 90000 rpm, fixed angle, Beckman Coulter, Brea, CA, USA). EVs were either used 
immediately or stored at −80°C in DMEM + 5% dimethyl-sulfoxide. Fresh and stored EVs showed no 
differences in biological activity. EV size, distribution and number were evaluated through a NanoSight 
LM10 (NanoSight Ltd, Minton Park, UK), running the Nanoparticle Tracking Analysis 2.3 software, while 
surface markers by FACS (Guava easyCyte™ Flow Cytometer, Millipore, Burlington, MA, USA), as described 
in Mazzeo et al. (2018). In addition, EVs were analyzed by Western blotting for the presence/absence of the 
EV markers/contaminants CD63 (sc-5275, Santa Cruz Biotechnology Dallas, TX, USA), Tumor Susceptibility 
Gene 101 (TSG101, sc-101254, Santa Cruz Biotechnology), apolipoprotein A1 (ApoA1, ab52945, Abcam, 
Cambridge, UK) and Golgin subfamily A member 2 (GM130, ab52945, Abcam) (Suppl. Mat.1, Fig. 1). 
To control the efficacy of our isolation method, EV samples from the 3 groups were also separated by 
OptiPrep
TM
 (Sigma-Aldrich), through a modification of the method described by Collino et al. (2017). Briefly, 
gradient was formed by layering 2.5 ml of 40%, 2.5 ml of 20%, 2.5 ml of 10%, and 2 ml of 5% iodixanol 
gradient solution in polycarbonate tubes. 500 μl EVs were overlaid onto the top of the gradient, and tubes 
were centrifuged for 18h at 100,000 g at 4°C. Ten gradient fractions of 1 mL were collected from the top of 
the tube and the density of each fraction was measured by weighing a fixed volume. Each fraction was 
diluted with 10 ml PBS and further centrifuged at 100,000 g for 2h at 4°C. Pellets were re-suspended in 100 
μl PBS and used freshly. Combined fractions 4-6 were chosen for experiments, the density of them being 
1.11-1.13 g/ml, similar to the density range of small EVs separated by iodixanol gradient (1.115–1.145 
g/mL) (Kowal et al., 2016). 
The expression of the contaminants ApoA1 and Argonaute 2 (Ago2, ab57113, Abcam) was analysed in both 
ultracentrifugation and OptiPrep
TM
 EVs and compared with whole plasma (Suppl. Mat.1, Fig. 2). MiR21-3p, 
miR30b-5p and miR150-5p expressions were assessed by qRT-PCR in OptiPrep
TM
 EV samples from the 3 
groups (Suppl. Mat. 1, Fig. 3). 
2.4 Cell transfection 
To induce miR-21-3p and miR-30b-5p overexpression, subconfluent HRP/HMEC cultures were transiently 
transfected using HiPerFect Transfection Reagent (Qiagen, Hilden, Germany), with 5 nM miRNA mimics 
(Syn-hsa-miR-21-3p, MSY0004494, and Syn-hsa-miR-30b-5p, MSY0000420, Qiagen). Negative control 
cultures were transfected with Allstars Negative Control SiRNA (Qiagen). MiR-150-5p inhibition was 
obtained by adding to cell cultures 50 nM anti-hsa-Mir-150-5p (MIN0000451, Qiagen), or miScript Inhibitor 
Negative Control (Qiagen) for negative controls, according to manufacturer's instructions. Cells were also 
transfected with the mimics and antagomir all together. Transfection efficiency was assessed by RT-qPCR 
after 24-48 hrs (Suppl. Mat. 1, Fig.4). 
2.5 Cell migration 
Transfected HRPs or HMECs were seeded inside 8 µm pore polycarbonate membranes. After 24 hrs their 
migration rate was measured using the colorimetric QCM Chemotaxis Cell Migration Assay (Merck-
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Millipore, Darmstadt, Germany). Cells still inside the insert were removed and those migrated through the 
membrane stained. The stain was subsequently extracted and transferred to a 96-well ELISA plate for 
colorimetric reading at 560 nm. 
2.6 Vessel-like formation assay 
15,000 transfected HRPs and 15,000 transfected HMECs were seeded together onto Matrigel-coated 24-
well plates and cultured in DMEM. Co-cultures of non-transfected cells, as a control, were also established. 
After 24 and 48 hr incubation, phase-contrast photos at 100x magnification of five random fields per each 
well were captured. The total length of the network structures in each field was measured using the 
MicroImage analysis system (Casti Imaging, Venice, Italy), as previously described (Bussolati et al., 2003). 
Mean of the 5 fields of each well was calculated. Each measure was performed in duplicate wells and 
expressed as ratio of control (non-transfected cells). 
2.7 mRNA profiling 
mRNA profiling was performed on plasma EVs from 4 subjects in each group, chosen as the best matches 
with their correspondent subjects in the other two groups, to reduce as much as possible individual 
variations. Total RNA was extracted from EVs using mirVana RNA Isolation kit (Thermo Fisher Scientific, 
Waltham, MA, USA) and quantified spectrophotometrically (Nanodrop ND-1000, Wilmington, DE, USA). 50 
ng of total RNA were retro-transcribed to cDNA and pre-amplified using RT2 PreAMP cDNA Synthesis Kit 
(Qiagen). Expression of 84 genes involved in angiogenesis was evaluated using the RT² Profiler™ PCR Array 
Human Angiogenesis (PAHS-024Z) (Qiagen), according to the manufacturer’s instructions. qRT-PCR was 
performed using QuantStudioTM 12K Flex Real-Time PCR System (Applied Biosystems). Relative gene 
expression was determined using the 2
-ΔΔCT
 method. 
To validate the 7 mRNAs found to be differentially expressed, qRT-PCR was performed on plasma EVs from 
all individuals (7 subjects per each group). Total RNA was extracted using the mirVana RNA Isolation Kit and 
quantified spectrophotometrically. 50 ng of RNA were reverse-transcribed using High Capacity cDNA 
Reverse Transcription Kits (Thermo Fisher Scientific) and qRT-PCR performed using Power SYBR™ Green PCR 
Master Mix, by the QuantStudioTM 12K Flex Real-Time PCR System. mRNA expression was normalized 
against beta-2-microglobulin. 
2.8 Protein extraction 
To extract total proteins, EVs were lysed using M-PER Mammalian Protein extraction reagent 
(ThermoFisher) added with 10 µl/ml protease inhibitor cocktail kit (ThermoFisher). Extracts were kept ice-
cold and cleared by centrifugation at 20,000 g for 15 min at 4°C. Protein concentration was determined 
using the Bradford method. Supernatants were stored at −80°C.  
2.9 Western blot analysis 
30 µg proteins were loaded on pre-cast gels (4–15% Mini-PROTEAN® TGX™ Precast Gel, Bio-Rad, Irvine, CA, 
USA), separated by electrophoresis and transferred to nitrocellulose membranes. Immunoblotting was 
performed by incubating the membranes with specific antibodies, according to the manufacturer’s 
instructions. 
All primary antibodies were used at a 1:1000 dilution. Immunoreactive bands were visualized using the 
enhanced chemiluminescence (ECL) Western blotting protocol (Merck-Millipore). Antibodies used were: 
anti-HIF-1α (sc-8711, Santa Cruz Biotechnology), anti-Ang1 (sc-74528, Santa Cruz Biotechnology) and anti- 
β-actin (sc-47778, Santa Cruz Biotechnology).  
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The relative signal strength was quantified by densitometric analysis (ImageJ software, NIH, USA), and 
values normalized against β-actin.  
2.10 Statistical analysis 
Statistical comparisons among groups were carried out by one-way ANOVA with Bonferroni post-hoc 
correction. Results were considered significant for p≤0.05. SPSS software version 24.0 (IBM) was used for 
statistical analysis. 
 
 
3. Results 
3.1 EV characterization 
EV size, distribution and number were evaluated through NanoSight, and their surface markers by flow 
cytometry, as already described in Mazzeo et al. (2018). In addition, we further analysed EVs by WB for the 
presence/absence of EV markers/contaminants, choosing one protein from each category suggested by the 
Minimal information for studies of extracellular vesicles (MISEV) Guidelines 2018 (Théry et al., 2018): a 
transmembrane protein (CD63), a cytosolic protein (TSG101), the contaminant ApoA1 abundant in plasma, 
and GM130, whose absence demonstrates the specificity of EVs to the small EV subtypes (<200nm). Our 
results show the presence of the positive EV markers CD63 and TSG101, the depletion of ApoA1 in 
comparison with whole plasma, and the absence of GM130 (Suppl. Mat. 1, Fig. 1). To further check the 
efficacy of our isolation method, EV samples from the 3 groups were separated by both ultracentrifugation 
and OptiPrep
TM
 and the expression of the contaminants ApoA1 and Ago2 compared with whole plasma. 
The mean OptiPrep
TM
 – separated EV size was respectively 162±24 nm, 167± 83, 159±33 nm in the 3 groups 
(CTR, noDR, DR), comparable with those extracted by ultracentrifugation and described in Mazzeo et al. 
(2018). We found ApoA1 and Ago2 expressed in ultracentrifugation- and OptiPrep
TM
 – separated EVs from 
all groups, but their concentration was much lower than in plasma, in accordance with MISEV Guidelines 
2018 recommendations (Suppl. Mat.1, Fig. 2a). Moreover, normalizing densitometric values to CD63, a 
positive EV marker, we found no differences in Ago2 and ApoA1 concentrations between UC- and 
OptiPrep
TM
-separated EVs (Suppl. Mat. 1, Fig. 2b-c). Finally, miR21-3p, miR30b-5p and miR150-5p 
expression in OptiPrep
TM
-isolated EVs showed the same increase/decrease we had previously found in EVs 
separated by ultracentrifugation (Mazzeo et al, 2018) (Suppl. Mat. 1, Fig. 3). 
 
3.2 Transfection with miRNA mimics/antagomir increases HRP migration and HMEC/HRP vessel-like 
formation 
In our previous study (Mazzeo et al., 2018), we had found increased miR-21-3p and miR-30b-5p, and 
decreased miR-150-5-p inside EVs from diabetic patients with diabetic retinopathy; therefore, we 
transfected HMECs and HRPs with specific mimics/inhibitor (antagomir), as appropriate, for these miRNAs, 
to evaluate their functional role. In addition, we transfected cells with all mimics/antagomir together, to 
better evaluate the possible synergistic/antagonistic effects of the 3 miRNAs in the human subjects. 
Transfection efficiency was assessed after 24-48 hrs (Suppl. Mat.1, Fig. 4). 
No effects on HMEC migration following transfection were noticed (Fig. 1a), while HRP migration was 
increased in all cases: +53% vs non-transfected cells following miR-150-5p inhibition (p=0.005), +83% after 
miR21-3p-mimic transfection (p<0.05), +65% after miR30-b-5p-mimic transfection (p<0.05), and +80% 
(p<0.05) after transfection with all mimics/antagomir together (Fig. 1b). 
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Similarly, vessel-like formation in HMEC/HRP co-cultures in Matrigel was increased following transfection in 
all cases: +59% with miR-150-5p inhibitor vs non-transfected cells (p<0.05 vs non-transfected cells), +74% 
with miR-21-3p-mimic (p<0.05), +233% with miR30-b-5p-mimic (p<0.05), and +698% after transfection with 
all mimics/antagomir together (p<0.05 vs non-transfected cells and all single transfections) (Fig. 2). 
3.3 mRNA and protein profiling 
We examined the mRNA expression of 84 key-genes involved in the modulation of angiogenesis in plasma 
EVs derived from our 3 groups of subjects. Array analysis revealed 7 mRNAs to be differentially expressed in 
the 3 groups, especially as regards the DR group in comparison with healthy controls (CTR). In particular, 5 
of them were downregulated in DR vs CTR (p<0.05): angiopoietin-1 (Ang1), endoglin (ENG), neuropilin-1 
(NRP1), the angiopoietin receptor TIE1, and the tissue inhibitor of metalloproteinases (TIMP1). Eotaxin 
(CCL11) was downregulated in the noDR subjects vs CTR (p<0.05), while hypoxia-inducible factor 1α (HIF-
1α) was more than 2-fold upregulated in DR patients vs healthy controls (p<0.05) (Fig. 3). A complete list of 
the mRNAs expressed in the 3 groups without significant differences is shown in Suppl. Mat. 2. 
Subsequently, the expression of the differentially expressed mRNAs was investigated by qRT-PCR in all 
subjects (7 per each group). Ang1 was confirmed decreased in the DR group in comparison with healthy 
controls (-86%, p<0.005) (Fig. 4a), while HIF-1α was 2.5 fold higher in the noDR group and 3-fold higher in 
the DR group in comparison with controls (p<0.05 in both cases) (Fig. 4b). 
Ang1 and HIF-1α protein expression was also evaluated. While HIF-1α protein expression concurred with 
mRNA expression (+63 and +140% in no DR and DR groups in comparison with CTR, p<0.05 in DR/noDR vs 
CTR and in DR vs noDR) (Fig.4 d,f), Ang1 protein expression was unchanged among the groups (Fig. 4c,e). 
 
4. Discussion 
Reliable and specific biomarkers for prognosis and prevention of diabetes and its complications are 
certainly needed. In this paper, we further addressed the molecular composition of circulating EVs from DR 
patients, in order to gain further insight in their characterization and evaluated the functional role of miR-
150-5p, miR-21-3p and miR-30b-5p in retinal microvascular cells. Our results support a role for intra-vesicle 
miR-150-5p, miR-21-3p and miR-30b-5p in diabetic retinopathy and their association with the hypoxic 
environment typical of this complication. 
A potential pitfall of this work may be the method of separation of EVs from plasma. There is no general 
consensus in the literature about the best protocol to isolate EVs. We are aware that ultracentrifugation 
does not result in a particularly pure EV preparation, but it is currently still commonly used. Other methods 
are much more challenging, time-consuming and operator-dependent and, therefore, scarcely applicable to 
routine clinical practice (Kalra et al., 2013). Moreover, according to MISEV guidelines, a complete 
separation and purification of EVs from possible contaminants, such as lipoproteins or Ago2, is currently 
rather impossible to achieve (Théry et al., 2018). To check the efficacy of our separation method, we 
compared a set of EVs from the 3 groups isolated by OptiPrep
TM
 with EVs separated by ultracentrifugation, 
and found comparable presence of ApoA1 and Ago2, much lower in both cases than in whole plasma. In 
addition, we found superimposable expressions of the three miRNAs of interest to those we previously 
described in ultracentrifugation-separated EVs (Mazzeo et al. 2108). Finally, in accordance with the MISEV 
Guidelines 2018 (Théry et al., 2018), we further analyzed EVs separated by ultracentrifugation for the 
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expression of the EV markers CD63 and TSG101, and the absence of GM130, the latter demonstrating their 
specificity to the small EV subtypes (< 200 nm). 
We have previously demonstrated that circulating EVs from patients with diabetic retinopathy induce 
features of retinopathy in in vitro models of retinal microvasculature, such as pericyte detachment and 
migration, new vessel formation and increased retinal-blood barrier permeability.  Moreover, we found 
molecular differences in EVs from DR subjects when compared to healthy controls and non-complicated 
diabetic patients, hypothesizing a role for miR-150-5p, miR-21-3p and miR-30b-5p as potential biomarkers 
of the onset of diabetic retinopathy (Mazzeo et al., 2018). Previous reports in the literature have already 
postulated a role for miR-150-5p, highlighting its ability to inhibit angiogenic factors in vitro, and showing 
its reduction during pathological neovascularization in mice with oxygen-induced proliferative retinopathy 
(Liu CH et al., 2015). On the other hand, miR-21-3p was found overexpressed in the retina of db/db mice 
(Chen Q et al., 2017), and to induce angiogenesis by mediating an increase in HIF-1α and VEGF expression 
(Báez-Vega et al., 2016; Snowhite et al., 2017). A role as a pro-angio-miRNA for miR-30b-5p, promoting EC 
migration and tube formation in vitro, has also been reported (Gong et al., 2017). 
To better evaluate the possible role of miR-150-5p, miR-21-3p and miR-30b-5p, we transiently transfected 
pericytes and ECs with an inhibitor (antagomir) of miR150-5p, which was decreased in EVs from DR 
subjects, and with specific mimics of miR-21-3p and miR-30b-5p that, conversely, had been found 
increased. MiRNA mimics are double-stranded RNA fragments which imitate endogenous miRNA functions 
once transfected inside cells, while single-stranded antagomirs specifically bind to their target miRNA 
inhibiting it. The use of these artefacts to better understand the role of endogenous miRNAs inside the cells 
is well described (Krützfeldt et al., 2005; Rupaimoole and Slack, 2017) and their potential use as prognostic 
and therapeutic approaches for cancer (Rupaimoole and Slack, 2017), inflammation (Tili et al., 2013) and 
chronic diseases such as diabetes and even diabetic retinopathy (McArthur et al., 2011) has been 
postulated.  In our settings, pericytes transiently transfected with mimics/antagomir showed increased 
migration, while the number of newly-formed vessel-like structures was amplified in transfected 
EC/pericyte co-cultures grown in Matrigel, especially when cells were transfected simultaneously with all 
mimics/antagomir together, demonstrating a strong synergistic effect of the three miRNAs together. These 
data strongly support the hypothesis of an involvement of miR-150-5p, miR-21-3p and miR-30b-5p in the 
pathogenesis of diabetic retinopathy. As regards mRNA profiling, array analysis showed that seven mRNAs 
related to angiogenesis were differentially expressed in the three groups, especially in the DR group 
compared to healthy controls, six of them downregulated, and one upregulated. However, subsequent 
control RT-PCR confirmed only two of them to be modulated in the different groups: Ang1, which was 
decreased in the DR group in comparison with controls, and HIF-1α, upregulated in both noDR and DR 
groups. 
Ang1 involvement in angiogenesis is controversial. It is known to play a fundamental role in pericyte 
recruitment and vessel stabilization during embryonic life and in physiological conditions, and has been 
associated to tumor angiogenesis (Metheny-Barlow and Li, 2003; Shim et al., 2007). On the other hand, its 
role in vessel stabilization may limit abnormal neo-vascularization and overexpression of Ang1 has been 
reported to inhibit tumor growth in different types of cancer (Metheny-Barlow and Li, 2003; Shim et al., 
2007). A protective role for Ang1 in diabetic retinopathy has also been postulated. In fact, Ang1 has been 
demonstrated to promote healthy vessel formation while inhibiting abnormal angiogenesis, impaired 
permeability and even neurodegeneration in oxygen-induced retinopathic mice (Lee et al., 2013), while a 
single-dose intra-vitreal injection of Ang1 vehiculated by an adeno-associated virus serotype 2 was able to 
prevent neurovascular pathology and promote vascular regeneration in a mouse model of diabetic 
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retinopathy (Cahoon et al., 2015).  Reduced Ang1 secretion was also described in retinal endothelial cells 
grown in high glucose concentrations (Stewart et al., 2016). Therefore, the decreased Ang1 mRNA 
expression we found in EVs derived from DR patients might play a role in pericyte loss, vessel 
destabilization and, potentially, increased neo-angiogenesis. However, Ang1 protein expression inside EVs 
was unchanged among the three groups. Differences between mRNA and protein expression often occur 
and can be ascribed to the complex cell regulation mechanisms at transcriptional and/or translational level 
and to the different half-lives of mRNA and proteins inside the cytoplasm (Greenbaum et al., 2003). Thus, 
cells may implement strategies to counteract damages caused by pathologically low (or high) 
mRNA/protein levels.  
Our data show also increased HIF-1 α mRNA and protein expression in EVs derived from both the noDR and 
DR groups, in comparison to healthy control. Moreover, HIF-1 α protein expression in EVs from the DR 
group was significantly higher also in comparison with the noDR group. HIF-1α role in angiogenesis and 
diabetic retinopathy is well known. The hypoxic environment inside the diabetic eyes leads to the activation 
of HIF-1α, which translocates inside the nucleus and activates target genes such as VEGF (D’Amico et al., 
2018). This, in turn, is a potent pro-angiogenic factor and currently the main target of diabetic retinopathy 
therapy (Bandello et al., 2013). We previously described an increase in HIF-1α and VEGF, following a 
concomitant decrease in miR-126, in human retinal pericytes exposed to EVs extracted by mesenchymal 
stem cells cultured in a hyperglycemic/hypoxic milieu (Mazzeo et al., 2015). In hypoxic conditions, 
increased HIF-1α activates several miRNAs, among which miR-30b-5p (Camps et al., 2014; Choudhry and 
Mole, 2016) and miR-21 (Liu Y et al., 2014; Choudhry and Mole, 2016). In turn, miR-21-3p promotes 
angiogenesis through AKT and ERK activation and increased HIF-1α expression (Liu LZ et al., 2011, Báez-
Vega et al., 2016; Snowhite et al., 2017), while miR-30b-5p directly induces in vitro EC migration and tube 
formation (Gong et al., 2017) . Moreover, a recent report correlates miR-150-5p with HIF-1α through 
ITGA6, a gene overexpressed in cancer and involved in cancer cell migration and invasion, and whose 
expression is downregulated by miR-150-5p and upregulated by HIF-1α (Koshizuka et al., 2017).  Thus, 
decreased miR-150-5p and increased miR-21-3p, miR-30b-5p and HIF-1α, as we found in EVs derived from 
DR subjects, may all together concur to vessel destabilization and angiogenesis. The fact that all these 
molecules are involved in hypoxia-induced damage, characteristic of the diabetic eye, may explain why we 
found them up or downregulated in the DR group, and therefore we think that they may be taken into 
account as markers of diabetic retinopathy.  
5. Conclusions 
Our data strengthen the hypothesis of a role of miR-150-5p, miR-21-3p and miR-30b-5p in the pathogenesis 
of diabetic retinopathy and their strong correlation with the hypoxic environment characteristic of the 
disease. In addition, we would suggest that miR-150-5p, miR-21-3p and miR-30b-5p extracted from 
circulating EVs may have a role as prognostic biomarkers of the onset and development of this 
complication. Further studies are needed to confirm this hypothesis, enrolling a larger number of subjects. 
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Figure captions 
 
Fig. 1 Transfection with miRNA mimics or antagomir increases HRP, but not HMEC, migration. a) HMEC, b) 
HRP. ctrl = non-transfected cells, inib neg ctrl = cells transfected with miScript Inhibitor Negative Control, 
anti-miR-150-5p = cells transfected with miR-150-5p antagomir, mim neg ctrl = cells transfected with 
Allstars Negative Control SiRNA, mim miR-21-3p = cells transfected with miR-21-3p mimic, mim miR-30-5p = 
cells transfected with miR-30-5p mimic, all mimics/antagomir = cells transfected with all mimics/antagomir. 
Fold increases vs ctrl, n=5, * p<=0.05 vs ctrl and relevant negative control.  
 
Fig. 2 Transfection with miRNA mimics or antagomir increases in vitro formation of vessel-like structures 
by HRP/EC co-cultures. a-d) Vessel-like structure formation by a) non-transfected cells (ctrl); b) cells 
transfected with miR-150-5p antagomir; c) cells transfected with miR-21-3p mimic; d) cells transfected with 
miR-30-5p mimic. Magnification 100x. e) Quantitative analysis of newly-formed vessel-like structures after 
24 hr in Matrigel, ctrl = non-transfected cells, inib neg ctrl = cells transfected with miScript Inhibitor 
Negative Control, anti-miR-150-5p = cells transfected with miR-150-5p antagomir, mim neg ctrl = cells 
transfected with Allstars Negative Control SiRNA, mim miR-21-3p = cells transfected with miR-21-3p mimic, 
mim miR-30-5p = cells transfected with miR-30-5p mimic, all mimics/antagomir = cells transfected with all 
mimics/antagomir. Fold increases vs ctrl, n=5, * p<=0.05 vs ctrl and relevant negative control, # p<0.05 vs 
anti-miR-150-5p, mim miR-21-3p and mim miR30-5p. 
 
Fig. 3 mRNA profiling in plasma EVs extracted from healthy subjects (CTR) and from diabetic patients 
without (noDR) and with retinopathy (DR), expression of the 7 differentially expressed mRNAs, fold 
increases vs the control group (CTR). White bars: CTR, light grey bars: noDR, dark grey bars: DR. n=4 per 
group, * p<0.05 vs CTR, # p<0.05 vs noDR.   
 
Fig. 4 Ang 1 and HIF-1α mRNA and protein expressions in plasma EVs extracted from healthy subjects 
(CTR) and from diabetic patients without (noDR) and with retinopathy (DR), fold increases vs the control 
group (CTR). White bars: CTR, light grey bars: noDR, dark grey bars: DR. a) Ang-1 and b) HIF-1α mRNA 
expression, n=7 per group, * p<0.05 vs CTR; c-e) Ang-1 and d-f) HIF-1α protein expression: c-d) 
quantitative analysis, n=7 per group, * p<0.05 vs CTR, # p<0.05 vs noDR; e-f) representative images of one 
relevant Western blot.  
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Highlights 
 
• Prognostic biomarkers for diabetic retinopathy are needed 
• Functional studies confirm miR-150-5p, miR-21-3p, miR-30b-5p involvement  
• HIF-1α is also increased in extracellular vesicles from diabetic retinopathy subjects 
• miR-150-5p, miR-21-3p, miR-30b-5p and HIF-1α concur to hypoxia-induced angiogenesis 
• Intra-vesicle miR-150-5p, miR-21-3p, miR-30b-5p as biomarkers of diabetic retinopathy  
